Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,228,792
+$449,488 QoQ
Shares Held
12,831
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#1,600
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Wealth Advisors, LLC holds $29,228,180 across 9 Drug Manufacturers - General names. ABBV ranks #2 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,369 | $14,835,750 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
12,831 | $3,228,792 | |
| 3 | JNJ |
Johnson & Johnson
|
10,046 | $2,551,382 | |
| 4 | AMGN |
Amgen Inc
|
6,063 | $2,195,533 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,197 | $1,919,988 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,560 | $1,818,487 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,036 | $1,418,126 | |
| 8 | PFE |
Pfizer Inc
|
44,086 | $1,061,590 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,228,792 | 12,831 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,779,304 | 12,779 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,893,597 | 12,664 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,926,202 | 12,638 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,335,842 | 12,584 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,738,426 | 13,070 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,314,897 | 13,027 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,568,227 | 13,005 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,290,478 | 13,354 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,397,528 | 13,166 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $729,908 | 4,710 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,930,923 | 12,954 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,800,396 | 13,363 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,224,805 | 13,960 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,321,850 | 14,367 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,904,439 | 14,190 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,080,065 | 13,581 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,040,802 | 12,589 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,831,420 | 13,526 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,242,338 | 11,517 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,424,220 | 12,644 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,353,832 | 12,510 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,237,261 | 11,547 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $905,067 | 10,333 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $560,116 | 5,705 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $278,169 | 3,651 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||